On the treatment of myasthenia gravis.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000549:Ambenonium Chloride / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D009388:Neostigmine / Q000627:therapeutic use; D011379:Prognosis; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D011878:Radiotherapy; D013950:Thymus Gland / Q000002:abnormalities / Q000601:surgery; D013953:Thymus Neoplasms / Q000150:complications
D009388:Neostigmine; D000549:Ambenonium Chloride; D011729:Pyridostigmine Bromide